BioX2 (Biological Exploration Payload 2) is targeted for launch to the International Space Station (ISS) in October 2022 to be a technological demonstration for biological sample automation, nucleic acid extraction, and nanopore sequencing in space. A stretch goal is to perform end-to-end operations on orbit and measure Darwinian evolution of Bacillus subtilis, which will help advance future space life detection missions.
This project is the successor to BioX1, and more information is available here: